Winslow Lab

Publications

Arora, N; Risma, K; Kwan, M; Winslow, A. Penicillin Allergy Decision & Mobile Empowerment (PADME)-Ideation and design of a novel delabeling program for children. Journal of Allergy and Clinical Immunology: In Practice. 2025.

Winslow, A; Mills, C; Schwartz, JT; Assa'ad, A. Implementing Food Oral Immunotherapy Into Clinical Practice: Quality and Safety Perspectives From a US Academic Center. Journal of Allergy and Clinical Immunology: In Practice. 2024; 12(5):1159-1169.

Pfirrman, S; Devonshire, A; Winslow, A. Environmental Interventions for Preventing Atopic Diseases. Current Allergy and Asthma Reports. 2024; 24(5):233-251.

Winslow, A; Gilmore, A; Kim, EH. Peanut anaphylaxis in 2022: Decoupling epinephrine usage from emergency department evaluation. Annals of Allergy, Asthma and Immunology. 2022; 129(3):382-384.

Winslow, A; Keet, CA. Preventing allergies through the skin. Annals of Allergy, Asthma and Immunology. 2022; 129(3):276-285.

Winslow, A; Jalazo, ER; Evans, A; Winstead, M; Moran, T. A De Novo Cause of PGM3 Deficiency Treated with Hematopoietic Stem Cell Transplantation. Journal of Clinical Immunology. 2022; 42(3):691-694.

Jalazo, E; Felton, T; Winslow, A; Montgomery, N; Weimer, E; Moran, T; Spence, J. eP281 A novel de novo PGM3 pathogenic variant identified in an infant presenting with abnormal TREC assay and severe neutropenia. Molecular Genetics and Metabolism. 2021; 132:s178.

Winslow, A; Jalazo, E; Felton, T; Weimer, E; Montgomery, N; Winstead, M; Moran, T. A Novel De Novo PGM3 Pathogenic Mutation Identified in an Infant Presenting with Abnormal TREC Assay and Severe Neutropenia. Journal of Allergy and Clinical Immunology. 2021; 147(2):ab70.

Winslow, A. The very preterm neonate's role in prevention of atopic disease. Journal of Allergy and Clinical Immunology. 2019; 143(5):1972.